Medicine - Oct 19
Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC Phase II study efficacy data showed overall response rate of 72.0% and 39.1%, respectively, in treatment-naive and previously treated patients with advanced MET exon-14 skipping
Astronomy - Oct 19
Astronomy

ESA Human Spaceflight - Astronauts - International Space Station Research - Exploration - 19 October 2018 - Imagine you are on Mars and you stumble upon an interesting rock.

Physics - Oct 19
Physics

Scientists discover the first high-temperature single-molecule magnet. This could be relevant for molecule-based magnetic information storage materials.

Medicine - Oct 19
Medicine

There is no cure for people with Alzheimer's disease or other dementia, and medical interventions for people with these conditions are limited.

Medicine - Oct 19

A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

    » Search among 7945 job offers in science and innovation.
    Selected Job Offers
    Employers of the Week